Gene expression profiling in livers of mice after acute inhibition of β-oxidation 
Introduction
Defects in mitochondrial β-oxidation are associated with hypoketotic hypoglycemia and the accumulation of fat in organs such as the heart and the liver. Ectopic fat accumulation has been implicated in the development of metabolic derangements occurring in insulin-resistant states. The mechanisms underlying this relationship have only been partly revealed. It is known that in the liver nuclear receptors like peroxisome proliferator-activated receptor-α (PPAR-α) and hepatocyte nuclear factor 4 (HNF4) play pivotal roles in the genomic responses on accumulated intermediates of LCFA(long-chain fatty acids) metabolism [1] [2] [3] [4] [5] . The use of transcriptome analysis ("transcriptomics") should reestablish their roles, even though transcriptome analysis is limited to the measurement of steady-state levels of mRNA and the mRNA levels of these receptors themselves could remain unchanged. Next to these established pathways, new avenues of research can be opened with unbiased gene expression profiling as a first step toward addressing potential metabolic implications that were previously unknown.
Carnitine palmitoyltransferase I (CPT-I) is a key enzyme in the regulation of the mitochondrial β-oxidation of long-chain fatty acids [6, 7] . The enzyme resides in the outer mitochondrial membrane [8] and is naturally inhibited by malonyl-CoA [6] , the product of the first reaction in de novo fatty acid biosynthesis. The consequences of CPT-I inhibition include the accumulation of LCFA derivatives such as triglycerides (TGs), which is considered one of the earliest events in the development of insulin resistance [5, 9] . Control of hepatic fatty acid metabolism, which is strongly interrelated with hepatic carbohydrate metabolism, plays a central role in the maintenance of whole body energy metabolism, particularly during fasting [1, 10] . Processes involved in fatty acid metabolism are subject to stringent (post)-transcriptional control. Early events that occur during the development of nonalcoholic fatty liver disease (NAFLD), a condition that generally predisposes to nonalcoholic steatohepatitis (NASH), are of crucial importance since at this stage deleterious consequences may still be reversible. Whereas "chronic" NASH has been studied at various levels, including the application of microarray analysis [11] , information on acute effects of hepatic lipid accumulation on hepatic gene expression is limited. Recent work has yielded considerable insight into the molecular mechanisms underlying the hepatic gene responses induced by fasting, a condition associated with "physiological" and reversible hepatic steatosis due to release of excess fatty acids from adipose tissue [12] ,which appears to be governed largely by PPAR-α [1] [2] [3] .
However, the genome-wide consequences of a rise in cytosolic LCFA and long-chain acyl-CoA (LCAC) as such are not known. Therefore, we performed gene expression profiling in a model of acute hepatic steatosis induced by blocking LCFA β-oxidation to gain insight at the level of the transcriptome. Tetradecylglycidic acid (TDGA) was applied in mice to irreversibly inhibit CPT1 [7] . The model is characterized by massive microvesicular hepatic steatosis within a 12-h time frame, accompanied by the accumulation of TGs and nonesterified fatty acids (NEFA) in plasma. [13] . Under these conditions, gluconeogenesis was found to be only slightly suppressed while hepatic glucose production remained unaffected. TDGA-induced inhibition of FA oxidation in perfused rat livers decreased the hepatic ATP/ADP ratio by about 20% [14] . These data indicate that TDGA treatment does not induce an acute energy crisis in hepatocytes.
We aimed to quantify the degree of LCAC accumulation and to relate this to hepatic gene expression profiles in mice. Unbiased profiling was performed through the application of oligomer microarrays, whereas the expression of a selected number of genes was measured by quantitative realtime PCR. This acute model of hepatic steatosis revealed concerted changes in the expression of genes of major pathways in energy metabolism and hepatic cell cycle control and emphasizes a role for transcription factors and coregulators, such as HNF4, PPAR-α, and PGC-1α as well as of IGF-1. Surprisingly, the results show strong inhibition of several genes involved in hepatic bile acid metabolism and transport.
Results and discussion
Long-chain acyl-CoA accumulation in the livers of TDGA-treated mice Quantification of hepatic TG content (+ 560%) and oil red O staining for neutral lipids confirmed the massive hepatic steatosis in TDGA-treated mice [13] . As expected from the site of action of TDGA, LC-acyl-CoA esters accumulated in the livers of TDGA-treated mice (Fig. 1) . LCAC profiling revealed significantly (P b 0.05) higher levels of myristoyl-(C14:0), palmitoyl (C16:0), palmitoleoyl-(C16:1), and oleoyl-(C18:1) CoA esters in livers of TDGA-treated mice. The accumulation of oleoyl-CoA was the most prominent. A predominance of 18:1 acyl species was also found in the VLDL-triglyceride profile obtained in the same model [13] . The total hepatic LCAC increase was less than 2-fold between control (123 ± 48 nmol LCAC/g liver) and TDGA-treated mice (212 ± 48 nmol LCAC/g liver) (P = 0.006). This moderate increase probably is a consequence of rapid incorporation of LCAC into triglycerides (control, 19.9 ± 8.3 μmol/g liver, vs TDGA, 112.4 ± 25.2 μmol/g liver). As described [13] , the TDGA-treated mice were hypoglycemic compared to controls during the course of the experiment, probably reflecting the use of glucose as energy source instead of fatty acids.
Global analysis of hepatic gene expression
For microarray analysis, we used two linear statistical approaches which, when combined, revealed a robust set of differentially expressed genes that was partly confirmed by realtime PCR analysis (see below). Principal component (PC) analysis on the complete data set showed that the second PC was informative for the hybridizations [15] of test versus control samples (Fig. 2, loop1 and loop 2) whereas this second component did not apply to the two self-self experiments. Employing a threshold for the standard deviation exceeding two (SD N 2) yielded 403 genes to be differentially expressed according to PC analysis. Fig. 1 . Long-chain acyl-CoA profiles of livers from control and TDGA-treated mice.Tandem mass spectrometry after HPLC prepurification was used to obtain the LCAC profiles of livers from control (white bars, n = 5) and TDGA-treated (black bars, n = 6) mice. Asterisks denote significant (P b 0.05) differences between specific chain-length LCAC species. All values represent means ± SD for the number of animals indicated. Statistical analysis was carried out by applying the Mann Whitney U test.
The second statistical approach made use of array analysis according to the BRB software package from NIH. Raw data were filtered for reliability (allowing maximally 3 out of the 12 measurements per gene to be flagged or missing), which yielded 3226 genes. Of these genes, 411 were differentially expressed according to the criterion P b 0.001.
The two sets of genes thus obtained had 232 differentially expressed genes in common, 52 of which were more than 2-fold higher expressed and 29 were more than 2-fold lower expressed in TDGA-treated animals compared to control animals. The full list of differentially expressed genes is added as Supplemental Table 2 .
Real-time PCR
We measured the hepatic expression levels of 44 genes selected on the basis of reported function, by quantitative realtime PCR. Supplemental Table 1 lists all previously unpublished primers and probes used for real-time PCR. A list of the "fold change" values of the 44 genes determined by real-time PCR can be found in Supplemental Table 3 . From the total of 232 differentially expressed genes identified by microarray as described above, 17 were tested for their expression level by real-time PCR. With the exception of one (the Pygl gene encoding glycogen phosphorylase), differential expression of all these genes was confirmed by real-time PCR. The direction of change and the "fold change" of these genes was comparable between microarray and real-time PCR (Fig. 3) .
In addition, we determined the expression of several genes that did not show up in the microarray experiments. These genes were not represented on the chip (e.g., Acaca; Cpt1b), not in the filtered list of 3226 genes (e.g., Acacb), or showed P values higher than 0.001 in the microarray analysis (e.g., Cpt1a; Pdk4; Cyp8b1; Cyp7a1). However, these genes encode proteins that are considered of importance in hepatic lipid, carbohydrate, and bile acid metabolism and are intensively studied in our laboratory. The set of 232 genes obtained from microarray selection was increased by the differentially expressed genes according to real-time PCR to 250 genes. This set was used to create network representations. Global gene ontology analysis on the unbiased group of 232 genes indicated that most of the affected genes related to primary metabolic processes (Supplemental Table 4 ). For further interpretation we divided the differentially expressed genes into ontologically related subsets (Tables 1−6 ). The major subsets of differentially expressed genes are related to mitochondrial (Table 2 ) and peroxisomal (Table 3) functions including genes involved in lipid metabolism (Fig. 4 ), carbohydrate metabolism (Table 4) , amino acid metabolism (Table 5) , bile acid metabolism (Fig. 5) , and apoptosis (Table 6 ). Transcription factors, central players in these processes, are listed in (Table 1) . Surprisingly, no distinct subset of genes related to inflammation appeared to be induced in this acute model of hepatic steatosis. Likewise, no indications for macrophage infiltrations were evident from microscopical examination of liver sections. This is in contrast to high-fat diet-induced hepatic steatosis in mice, in which rapid macrophage infiltration was recently reported to preced fat accumulation [16] .
Insulin-sensitive genes are differentially expressed at the transcriptional level
Since hepatic insulin sensitivity appeared to be unaffected at the level of VLDL formation and phosphatidylinositol-3 kinase phosphorylation on TDGA treatment [13] , we initially focused our attention on metabolic pathways that can be modulated by insulin. Several genes encoding proteins affected by insulin were found to be differentially expressed on TDGA treatment. The gene encoding SREBP-1c (sterol regulatory element binding protein-1c) was lower expressed in the livers of TDGA-treated mice compared to control (2.6-fold), whereas the Pdk4 gene for pyruvate dehydrogenase kinase 4 and Ppargc1a (for PPAR gamma coactivator 1α; PGC-1α) were higher expressed (29.1-and 2.4-fold, respectively). These genes are all known to be highly insulin responsive: their strong regulation is compatible with a lowering of plasma insulin levels due to hypoglycemia on β-oxidation inhibition. Downstream targets of these proteins were switched off, e.g., Gck, Pklr, and Pkm2 encoding glucokinase and liver-and muscle-type pyruvate kinase, respectively. Thus, genes involved in glycolysis were switched off and the key gene enabling inhibition of pyruvate oxidation (Pdk4) was switched on, probably reflecting responses aimed at sparing of glucose. In the condition of suppressed β-oxidation the body entirely depends on available glucose because neither ketone bodies nor energy needed for gluconeogenesis are being generated. The higher expression of Ppargc1a also known to occur during the fasting response could be a potential signal to increase gluconeogenesis [17, 18] . G6pc (encoding the catalytic unit of glucose 6-phosphatase) was indeed higher expressed on treatment but expression of G6pt (Slc37a4), encoding the transporter subunit of glucose 6-phosphatase, was reduced and that of Pck1 (Pepck for phosphoenol pyruvate carboxylase kinase) remained unaffected. The indifferent and low expression of the genes Acaca for acetyl-CoA carboxylase 1 and Fasn for fatty acid synthase, both involved in lipogenesis, is also compatible with low insulin levels, leading to suppressed SREBP-1c expression. These genes were already expressed at such low levels in the fasted control state that further down-regulation was not anticipated. Repression of the Mlxipl gene (3.45 times down) for the glucose-sensing transcription factor ChREBP (carbohydrate response element binding protein) is fully in line with impaired lipogenic gene transcription [19, 20] .
Genes involved in fatty acid oxidation are induced by a feedback mechanism
The massive changes in expression of genes encoding mitochondrial proteins may be part of a PGC-1α-mediated response. PGC-1α is the central orchestrating coactivator for mitochondriogenesis. Since mitochondria and peroxisomes are primary sites for oxidative processes it was not surprising to find many genes of fatty acid oxidation to be up-regulated. a Note that some of these gene products are better known for their functions in other pathways (like fatty acid metabolism) but also act in steps of amino acid metabolic pathways. Most of the genes involved are under the control of peroxisome proliferator-activated receptor α (PPAR-α, which is coactivated by PGC-1α). Since TDGA itself may act as a PPAR-α ligand [21] , part of these effects may be a direct consequence of the treatment. These responses are characterized by overexpression of Cpt1a and Cpt1b, as well as other genes involved in β-oxidation (Cpt2; Acadl; Acadm) and LCFA partitioning (Slc25a20; Ucp2; Ucp3). The 5-fold increase in expression of the latter gene is in line with its proposed role as a mitochondrial fatty acid efflux protein [22] . Besides these feedback mechanisms, feed forward mechanisms may be involved as well. The response seems to anticipate a larger acetyl-CoA pool: the Crat gene encoding the buffering enzyme carnitine acetyltransferase was 3-fold higher expressed in the treated group. Carnitine acetyltransferase is important for both mitochondrial and peroxisomal acetyl-CoA and acetylcarnitine homeostasis [7] . Cellular carnitine uptake could be facilitated by the strong induction (almost 4-fold difference) of the gene encoding the plasma membrane carnitine transporter OCTN2. Many genes involved in the intracellular transport and the β-oxidation of LCFA are PPAR-α targets. Therefore, it is not surprising that PPAR-α is centrally positioned in a global pathway analysis such as depicted in Fig. 4 . Surprisingly, the Acacb gene for acetyl-CoA carboxylase 2 (ACC2) was 1.72-fold higher expressed in treated mice. This is remarkable since ACC2 is the isoform primary responsible for inhibition of CPT1 by malonyl-CoA in the liver [23] . Therefore, it was unexpected that this gene would become up-regulated in a situation of artificial inhibition of CPT1. The regulation of transcription of Acacb has not been elucidated [24] and our findings provide clues for further investigations.
In addition to PPAR-α as intracellular sensor of LCFA, it has been indicated that hepatocyte nuclear factor 4 is important in the concerted regulation of genes encoding the LCFA metabolic machinery. HNF4 is considered a master switch in the control of metabolic genes [4, 5] and its importance in the development of diabetes is well-recognized [25] . As depicted in Supplemental Tables 2 and 3 , 59 out of the 250 differentially expressed genes were associated with HNF4, accounting for 24% of total, indicating a major role of this nuclear receptor in the responses observed.
Circumstantial evidence suggests signaling by LCFA rather than LCAC Blocking β-oxidation by TDGA results in hepatic accumulation of LCAC (Fig. 1) . This accumulation was moderate compared to the profound effects on triglyceride accumulation. We found that the two genes encoding acyl-CoA synthases (Acsl1 and Slc27a4) were more highly expressed in TDGAtreated mice than in controls (2.1-and 1.9 -fold, respectively). Both the Acsl1 gene [26] and the Slc27a4 gene for FATP4 [27] encode proteins that possess acyl-CoA synthetase activity. The latter contains a distinct peroxisome proliferator response element in its promoter [28] . The enzyme activities enable the A part of these networks is shown here, with black boxes for genes that are higher expressed, and white boxes for genes that were lower expressed in the livers of TDGA-treated mice. The gray box symbolizes unchanged expression of Ppara. The other gene symbols are explained in the text and tables. cell to covert LCFAs into their CoA esters which is needed for further partitioning.
When β-oxidation is blocked, LCFA are largely partitioned toward TG. The finding that the expression of two independent genes for acyl-CoA synthetases were induced provides circumstantial evidence, suggesting that the major effectors of the molecular cascades are the free LCFA rather than their CoA derivatives. Although acyl-CoAs are assumed to be important in the development of insulin resistance, the natural ligands of the nuclear receptors of the PPAR family and HNF4 are the free fatty acids rather than their CoA derivatives [3] [4] [5] . LCFA and LCAC accumulation can be detrimental due to the amphiphilic character of these molecules and, therefore, liver cells respond promptly by inducing the machinery to lower their concentrations. In addition, in nonliver tissue "futile cycling" has been proposed as an ATP-consuming mechanism through the action of fatty acid ligases and cytosolic thioesterase 1 (CTE1) [29] . Indeed, the gene for CTE1 was up-regulated 5-fold, suggesting that futile cycling is facilitated to occur in liver also. Alternatively, the hypoglycemia could be responsible for mobilization of fat resulting in high LCFA and elevated acyl-CoA synthase expression.
Triglyceride formation and proposed partial partitioning into VLDL
In the model studied, activation of LCFA could not be followed by β-oxidation and therefore the formation of TG in liver cells provided an immediate solution for avoiding intracellular LCFA and LCAC accumulation. Indeed, the Dgat1 and Gpam genes that encode enzymes required for TG formation were induced on TDGA treatment, allowing the partitioning of LCAC into TG. Dgat2 was lower expressed on the treatment, implying that the Dgat1 over Dgat2 ratio was increased. We reason that, despite the on-site accumulation of TG, a part of the TG is further partitioned into VLDL. As shown by Grefhorst et al. [13] , total VLDL-TG production was not affected on TDGA treatment but analysis of particle composition revealed an enrichment with C18:1 acyl species coinciding with the composition of hepatic TG. Therefore, part of the accumulated TG must have been incorporated into nascent VLDL particles. Apob (1.25-fold up) is well known for its decisive role in VLDL formation by hepatocytes; yet, control is mainly exerted at posttranscriptional level [30, 31] . The lower expression of Pemt is intriguing in this respect, since the Pemt gene product (phosphatidylethanolamine methyltransferase) is needed for the secretion of VLDL-apoB [32] . Interestingly, PEMT deficiency has recently been reported to aggravate hepatic steatosis in mouse models [33] .
Bile salt metabolism is massively affected on the blocking of β-oxidation An unexpected finding was the massive shift in expression of genes involved in bile salt metabolism and transport (Figs. 4  and 5) . The Cyp7a1 gene, encoding the rate-controlling enzyme in bile salts biosynthesis, was very strongly suppressed (21.5-fold) while Cyp8b1, which determines the cholate/chenodeoxycholate ratio, was 1.75-fold higher expressed. The transcriptional network including SHP (short heterodimer partner encoded by Nr0b2), LXR (liver X receptor encoded by Nr1h3), and FXR (farnesoid X receptor encoded by Nr1h4) as depicted in Figs. 4 and 5 may be involved in this regulation. PPAR-α is probably of prominent importance in this respect, as pharmacological PPAR-α activation leads to similar alterations in Cyp7a1 and Cyp8b1 gene expression in rodent livers [34, 35] .
It should be noted that the Ehhadh gene was drastically upregulated (6.7-fold higher in TDGA-treated mice). This gene is of relevance for bile salt metabolism since its product enoylCoA hydratase/CoA dehydrogenase, also known as L-bifunctional protein, catalyzes the alternative pathway of peroxisomal side-chain shortening. However, its up-regulation may be primarily a consequence of PPAR-α-mediated gene transcription and can be regarded as part of the orchestrated up-regulation of the β-oxidation machinery rather than an increased need for side-chain shortening of bile salts. These results highlight an as yet unknown relationship between the transcription of genes needed for bile salt synthesis (i.e., cholesterol catabolism) and the accumulation of intermediates of fatty acid metabolism.
Insulin-like growth factor and other central players show reduced expression after blocking β-oxidation
For several pathways (Fig. 4) , insulin-like growth factor 1 (IGF1) is a key regulatory protein. The gene encoding IGF1 was 1.46-fold underexpressed on TDGA treatment compared to control levels. In our analysis on pathway interconnections, IGF1 showed up as a primary site of regulation that results in changes in gene expression of major pathways of relevance for hepatic steatosis. A total of 10 genes known to be involved in apoptosis and antiapoptotic response were differentially expressed ( Table 6 ). Two of the highly up-regulated genes are known to induce cell death (the Cidec gene was 5.68-fold and the Tnfsf12 gene was 4.31-fold higher expressed). In addition, Cyp4a10 known as marker for lipid peroxidation and responsive to PPAR-α [36] , was 2.27-fold higher expressed on TDGA treatment. These responses are likely part of a process in the acute phase of steatosis development in which the liver cells have to find a new equilibrium between apoptotic and antiapoptotic activities. This is not surprising, given the fact that major consequences of blocking β-oxidation are related to mitochondria (Table 2) which have a central role in apoptotic cascades. Indeed, in a recent in vitro study employing liver slices, it was shown that blocking of LCFA β-oxidation may cause apoptosis, especially if the blockade is downstream of CPT1 [37] . However, in our study no signs of apoptosis or inflammation were observed, likely due to the short-term nature of the experiment.
Other effects that relate to lower expression of IGF1, and also of estrogen receptor1 (Erα, encoded by Esr) and epidermal growth factor receptor (EGFR) (Fig. 4) , are the genes that control cell cycle (suppression of oncogenesis), as well as fibrotic and antifibrotic responses (e.g., genes involved in collagen formation). These are obviously responses that are of relevance for the acute effects of hepatic steatosis and our data (added as Supplemental tables) may provide new angles to approach the molecular networks underlying these effects.
Comparison to other microarray studies
The number of studies applying high-throughput gene expression profiling in NAFLD is limited. These were carried out with livers from human subjects, which by definition reflect a more chronic state of steatosis. Compared to these studies, we observed a number of similarities. Apart from genes involved in fatty acid and carbohydrate metabolism as discussed above, we also encountered a large number of genes involved in amino acid metabolism (Table 5 ). Profound changes in energy metabolism are a plausible explanation for this finding, since many of the enzymes in amino acid metabolism are highly dependent on ATP and reducing equivalents. Part of these responses may be ascribed to PPAR-α activation [38] .
Compared to the literature there are also important differences in outcome. For instance, responses to prevent oxygen damage and to induce scavenging were clear-cut in the study by Sreekumar et al. [11] but appeared not (yet) of relevance in our acute model. Another example refers to the fact that out of the list of 232 differentially expressed genes (Supplemental Table 2 ) we only found 3 genes encoding constituents of the cytoskeleton and 4 for extracellular matrix proteins whereas analysis of a large number of human subjects) indicated an important role for extracellular matrix remodeling [39, 40] .
Chiappini et al. [41] studied biopsies that did not show histological features of inflammation and therefore may be considered as intermediate acute phase samples. Indeed, in terms of classification (mitochondrial metabolism, inflammation) their findings most closely resemble the data presented here, although many detailed differences are apparent. The difference in composition of gene sets present on the microarrays may contribute to these differences.
Concluding remarks
It is important to note that it is not possible to discuss the relevance and impact of all genes and clusters that were differentially expressed in this study. Therefore, this initial analysis is focused on pathways that provide insight in the major responses that occur during the acute phase of steatosis development. By the use of transcriptome analysis we reestablished the roles of some important nuclear receptors, even though the use of primary data was limited to (sets of) genes that were differentially expressed without measuring gene product activity. Through pathway analysis the subsequently distilled information revealed important factors, even though the mRNA levels of these receptors themselves sometimes remained indifferent. Our results show also that gene expression profiling can be used as a first step toward addressing previously unknown implications, like altered expression of genes involved in bile salt metabolism and transport.
Materials and methods

Animals and chemicals
Male wild-type C57BL/6J mice (Harlan, Horst, the Netherlands) were housed and treated according to protocols approved by the Animal Experiments Ethical Committee of the University of Groningen. The mice were housed under 12-h light/12-h dark regime and were fed normal chow (RMH-B, Hope Farms, Woerden, the Netherlands) and water ad libitum, until experimentation. Tetradecylglycydic acid (TDGA), a kind gift from Dr. P.J. Voshol (LUMC, Leiden, the Netherlands), was suspended at a concentration of 2.0 mg/ml in a solution consisting of 90 mg/ml bovine serum albumin in saline.
Animal experiments
Mice received an i.p. injection with 30 mg TDGA per kg bodyweight (n = 6) or vehicle (n = 6 unless stated otherwise). Food was withdrawn but mice still had access to water. After 12 h, the mice were killed by cardiac puncture under isoflurane anesthesia. The abdomen was opened and the liver was quickly removed and immediately frozen in liquid nitrogen and stored.
Acyl-CoA profiling
Extraction of LCAC was performed in frozen liver tissue according to Mangino et al. [42] with slight modifications. Hepatic LCAC content was determined by tandem mass spectrometry after HPLC prepurification (HPLC-MS-MS) (Perkin Elmer/Biosystems Sciex; and Applied Biosystems). Multiple reaction monitoring was performed to measure the different long-chain acylCoA thioesters. The transitions used were the doubly charged m/z precursor ion of LCAC at Q1 and the m/z product ion of the adenine residue at Q3. Full protocols of these procedures are available on request.
Microarrays
The microarrays used contained the complete mouse oligonucleotide library version 1 (Sigma-Genosys/Compugen) printed in duplicate on UltraGAPS slides (Corning, Reading, UK). The mouse oligonucleotide library version 1 consists of 7524 gene-specific 65-mer oligos representing 7445 genes from a diverse range of functionalities. In addition, positive and negative controls were represented on the arrays. These microarrays were obtained from the Department of Anthropogenetics at the Radboud University, Nijmegen, the Netherlands, and are known to provide robust data [43] .
RNA isolation and purification
Total RNA was isolated from 30 mg liver tissue by the use of Tri-Reagent (Sigma-Aldrich, Zwijndrecht, the Netherlands), according to the manufacturer's protocol. RNA was purified with a RNeasy min Elute Clean-up kit (Qiagen, Venlo, the Netherlands) according to the manufacturer's protocol. The integrity and concentration were determined on an Agilent Bioanalyser 2100 (Palo Alto, CA).
Probe construction, hybridization, and data acquisition
Labeling of cDNA molecules through incorporation of aminoallyl-labeled nucleotides was performed according to a protocol described at http://pga.tigr. org/sop/M004_1a.pdf. Briefly, for each RNA sample, first-strand aminomodified cDNA was synthesized by oligo(dT)-primed reverse transcription from 20 μg total RNA using Superscript II reverse transcriptase (Invitrogen, Paisly, UK) in the provided buffer and in the presence of 0.5 mM dATP, dCTP, dGTP, 0.3 mM dTTP, and 0.2 mM amino-allyl dUTP. After 16 h incubation at 42°C the RT reaction was stopped and cDNA was purified as described. Purified cDNA was fluorescently labeled with Cy3 or Cy5 fluorophores (Amersham Biosciences, Roosendaal, the Netherlands) as described previously [44] . Labeled cDNA was purified using Microcon YM-30 size-exclusion columns (Millipore, Amsterdam, the Netherlands).
Each probe was put together by mixing the labeled cDNA reactions from the appropriate samples together with 15 μg poly(dA) DNA (Qiagen, Hilden, Germany) and 7.5 μg human Cot-1 DNA (Invitrogen). This probe was heated at 95°C for 3 min, cooled to 52°C, and mixed with an equal volume of preheated (52°C) hybridization buffer to a final concentration of 25% formamide, 5X SSC (saline sodium citrate) and 0.1% SDS. All hybridizations were performed under lifterslips (Erie Scientific, Portsmouth, UK) within hybridization chambers (Telechem, Sunnyvale) in a waterbath at 52°C for 40 h. After hybridization the slides were washed, dried and scanned at 10 μm resolution in a GMS 428 laser scanner (Affymetrix, Santa Clara, CA). Image intensity data for each array feature was extracted by ImaGene 5.6 software (BioDiscoveries, Marina Del Rey, CA).
Microarray analysis and computation
A double loop design (Fig. 2) was applied to the microarray hybridization experiment to minimize the number of microarray slides and still include dyeswap readings for all samples [45] . In addition, a self-self hybridization was included for both the control and the treatment group to account for technical variation in the experiments. Expression analysis was performed by principal component analysis in SPSS (Chicago, IL) [15] and by gene expression analysis in the BRB-ArrayTools software package (BRB ArrayTools developed by Simon and Peng Lam. For this latter BRB ArrayTools analysis control spots were removed and raw array data were normalized for each printtip separately. Intensity data of oligomer spots considered as empty, bad, or negative were removed from the file and spots with more than 25% missing data across the experiment were not included in the analysis. Differentially expressed genes among the two classes were identified using a random-variance t test, an improvement over the standard separate t test as it permits sharing information among genes about within-class variation without assuming that all genes have the same variance [46] . Genes were considered statistically significant if their P value was less then 0.001. The datasets were compiled by the use of Genespring software. The most prominent gene ontologies were identified by DRAGON [47] , Gostat [48] , and DAVID [49] . Network presentations were created with Pathway Assist and Pathway Architect [50] (Iobion/Stratagene, Amsterdam, the Netherlands) for a primary setup, added with more detailed knowledge from the literature. The genes annotated for mitochondrial proteins and involvement in mitochondrial development were further curated according to the MiGene database [51] . A set of genes that appeared to be involved in amino acid metabolism was further identified by PathwayFinder/Pathway Miner [52] .
PCR procedures
cDNA synthesis was performed using recombinant M-MLV reverse transcriptase (Sigma-Aldrich, Zwijdrecht, the Netherlands). Real-time quantitative PCR was performed as previously described [12] . Primers (Invitrogen, Paisly, UK) and fluorogenic probes (Eurogentec, Seraing, Belgium) used in these studies were described elsewhere (http://www.LabPediatricsrug.nl) or listed in Supplemental Table 1 . All data were subsequently normalized to β-actin/18S rRNA ratio, which where analyzed in separate runs.
